For injectable GLP-1 medications currently in use , patients should be aware of common side effects including nausea, vomiting, diarrhea, and decreased appetite, particularly during dose escalation
Patients who switched from tirzepatide to orforglipron maintained a mean 74.7% of their body weight reduction from the SURMOUNT-5 trial compared with those in the placebo group, which maintained a mean 49.2% of their weight loss
Exercise is fine with a 30-minute buffer
How Sofwave Works Sofwave targets the mid-dermis with ultrasound energy, stimulating collagen production
Noom Med's providers can prescribe intermediate doses between standard increments to minimize side effects
Mixing injection sites risks altering the absorption of both compounds